Overheard Speech for Autism Spectrum Disorder

Phase-Based Progress Estimates
Autism Spectrum Disorder+1 More
Overheard Speech - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

This trial is looking to see if children with ASD can learn word meanings from overheard conversations, and if so, what child characteristics are associated with good learning in this situation.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism Spectrum Disorders

Treatment Effectiveness

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: immediately after intervention

after 5 minutes
Number of children who select the target object by touching, pointing, or grasping
Proportion of time during which children's eye gaze is directed toward the target object
immediately after intervention
Number of children who select the target object by touching, pointing, or grasping on each trial

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

155 Total Participants · 2 Treatment Groups

Primary Treatment: Overheard Speech · No Placebo Group · N/A

Experimental Group · 1 Intervention: Overheard Speech · Intervention Types: Behavioral
ActiveComparator Group · 1 Intervention: Addressed Speech · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after intervention

Who is running the clinical trial?

Emerson CollegeUNKNOWN
3 Previous Clinical Trials
595 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
495 Patients Enrolled for Autism Spectrum Disorder
New York UniversityLead Sponsor
199 Previous Clinical Trials
300,786 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
1,495 Patients Enrolled for Autism Spectrum Disorder

Eligibility Criteria

Age < 18 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: November 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
How old are they?
< 18100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%